Dermata Therapeutics, Inc. , a clinical-stage biotechnology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions.
Dermata Therapeutics stock last closed at $1.46, up 20.66% from the previous day, and has decreased 87.63% in one year. It has underperformed other stocks in the Biotechnology industry by 0.41 percentage points. Dermata Therapeutics stock is currently +31.53% from its 52-week low of $1.11, and -93.84% from its 52-week high of $23.70.
There are currently 1.03M DRMA shares outstanding. The market value of DRMA is $1.50M. In the last 24 hours, 38.88M DRMA shares were traded.
You will need a brokerage account in order to access the NASDAQ market and buy DRMA stock.
Based on our experience, eToro is the best brokerage. eToro gives you:
Get $10 towards your share purchase by creating an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've picked your brokerage, you need to fill out some personal info so you are able to buy DRMA stock today.
Now that you've created your account on the greatest app to buy stocks, you need to deposit funds:
Watch the walkthrough below for more details transferring money into your brokerage account.
Once you have chosen the best place to buy Dermata Therapeutics stock, it's absolutely critical to analyze their stock before you invest, so you actually wrap your head around the risk and opportunity.
WallStreetZen was designed to help average investors do more in-depth fundamental analysis quickly.
You can see all of the due diligence checks on DRMA's stock page.
Investors use a variety of different financial metrics, analyses, models, and charts to gauge DRMA's true value.
Using relative valuations measures:
You can do additional valuation analysis on DRMA's stock here.
You can dive deeper into what analysts are projecting on the Dermata Therapeutics stock forecast page.
Over the past 12 months, insiders at DRMA have bought more shares than they have sold.
Munera Maria E. Bedoyatoro, SVP Regulatory Affairs of DRMA, was the latest DRMA insider to buy. They bought $1,270.00 worth of DRMA shares on Feb 17, 2026.
Learn more about who owns DRMA stock here.
No, Dermata Therapeutics doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other community members have to say.
There are two primary types of orders:
Press the Open Trade button and eToro will place your order.
If you need additional help with buying stocks on eToro, watch the how to video below:
Now that you own some shares in DRMA, you'll want to stay up-to-date on your new investment.
Add DRMA to a watchlist to keep tabs on your DRMA stock.
To summarize, here are the 6 steps to buy stock in Dermata Therapeutics:
If you are looking for a online brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you want to get the latest scoop on your investment in Dermata Therapeutics, add DRMA to your watchlist by clicking the button below.